SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 77 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,899,236 | -64.5% | 4,984,871 | -22.7% | 0.04% | -63.2% |
| Q2 2023 | $5,354,223 | -31.4% | 6,450,871 | 0.0% | 0.11% | -34.5% |
| Q1 2023 | $7,805,554 | -39.8% | 6,450,871 | 0.0% | 0.17% | -35.1% |
| Q4 2022 | $12,966,251 | -26.7% | 6,450,871 | -8.9% | 0.27% | -23.9% |
| Q3 2022 | $17,695,000 | -26.9% | 7,078,019 | +11.7% | 0.35% | -29.5% |
| Q2 2022 | $24,205,000 | -42.0% | 6,336,330 | -4.2% | 0.50% | -46.5% |
| Q1 2022 | $41,722,000 | -60.4% | 6,612,019 | -27.4% | 0.93% | -57.8% |
| Q4 2021 | $105,335,000 | +3.3% | 9,112,019 | 0.0% | 2.21% | +11.0% |
| Q3 2021 | $101,963,000 | -59.3% | 9,112,019 | 0.0% | 1.99% | -55.3% |
| Q2 2021 | $250,398,000 | – | 9,112,019 | – | 4.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Revelation Capital Management, LLC | 2,219,951 | $14,008,000 | 51.22% |
| ARCH Venture Management, LLC | 3,798,926 | $23,971,000 | 3.43% |
| Tikvah Management LLC | 707,600 | $4,465,000 | 1.43% |
| Triatomic Management LP | 221,708 | $1,399,000 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,612,019 | $41,722,000 | 0.93% |
| Perceptive Advisors | 3,655,207 | $23,064,000 | 0.46% |
| Casdin Capital, LLC | 1,442,870 | $9,105,000 | 0.41% |
| Orbimed Advisors | 2,300,792 | $14,518,000 | 0.24% |
| Nicholas Investment Partners, LP | 519,885 | $3,280,000 | 0.23% |
| Alphabet Inc. | 586,584 | $3,701,000 | 0.12% |